Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 45 | 2025 | 1235 | 6.200 |
Why?
|
| Mammography | 28 | 2025 | 296 | 5.060 |
Why?
|
| Breast Diseases | 12 | 2023 | 45 | 3.050 |
Why?
|
| Contrast Media | 9 | 2025 | 435 | 2.390 |
Why?
|
| Breast | 11 | 2025 | 194 | 2.030 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 2324 | 1.550 |
Why?
|
| Image-Guided Biopsy | 5 | 2018 | 50 | 1.240 |
Why?
|
| Societies, Medical | 11 | 2024 | 401 | 1.240 |
Why?
|
| Early Detection of Cancer | 13 | 2024 | 327 | 1.110 |
Why?
|
| Radiographic Image Enhancement | 3 | 2025 | 99 | 1.000 |
Why?
|
| Female | 70 | 2025 | 34420 | 0.980 |
Why?
|
| Precancerous Conditions | 3 | 2021 | 74 | 0.890 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 274 | 0.880 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 413 | 0.870 |
Why?
|
| Humans | 84 | 2025 | 65831 | 0.810 |
Why?
|
| Homosexuality, Female | 1 | 2023 | 22 | 0.780 |
Why?
|
| Radiology | 5 | 2021 | 263 | 0.740 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 603 | 0.730 |
Why?
|
| Wernicke Encephalopathy | 1 | 2022 | 5 | 0.730 |
Why?
|
| Thiamine Deficiency | 1 | 2022 | 8 | 0.720 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 76 | 0.710 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2021 | 3 | 0.700 |
Why?
|
| Ultrasonography, Mammary | 6 | 2019 | 19 | 0.700 |
Why?
|
| Carcinoma, Lobular | 1 | 2021 | 28 | 0.690 |
Why?
|
| Carcinoma in Situ | 1 | 2021 | 36 | 0.680 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 5 | 0.660 |
Why?
|
| Practice Management, Medical | 2 | 2018 | 20 | 0.650 |
Why?
|
| Middle Aged | 29 | 2025 | 18498 | 0.640 |
Why?
|
| Cerebral Ventricles | 6 | 2011 | 29 | 0.590 |
Why?
|
| Biopsy | 4 | 2017 | 463 | 0.580 |
Why?
|
| Video Recording | 2 | 2017 | 140 | 0.580 |
Why?
|
| Retrospective Studies | 19 | 2025 | 6955 | 0.540 |
Why?
|
| Mass Screening | 7 | 2024 | 700 | 0.540 |
Why?
|
| Lymph Nodes | 2 | 2018 | 237 | 0.530 |
Why?
|
| Workflow | 1 | 2018 | 77 | 0.530 |
Why?
|
| Incidental Findings | 1 | 2017 | 51 | 0.510 |
Why?
|
| Adult | 28 | 2025 | 17575 | 0.510 |
Why?
|
| Sensitivity and Specificity | 10 | 2023 | 1172 | 0.490 |
Why?
|
| Aged | 19 | 2025 | 15145 | 0.480 |
Why?
|
| Teaching Materials | 1 | 2016 | 12 | 0.480 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 68 | 0.480 |
Why?
|
| Education, Medical, Graduate | 4 | 2023 | 347 | 0.480 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2011 | 50 | 0.470 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 31 | 0.470 |
Why?
|
| Stereotaxic Techniques | 2 | 2014 | 30 | 0.460 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 106 | 0.440 |
Why?
|
| Fetal Diseases | 4 | 2011 | 22 | 0.430 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 309 | 0.420 |
Why?
|
| Evidence-Based Medicine | 8 | 2024 | 464 | 0.420 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 175 | 0.410 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 993 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 312 | 0.380 |
Why?
|
| Biopsy, Large-Core Needle | 4 | 2021 | 22 | 0.380 |
Why?
|
| Prenatal Diagnosis | 4 | 2011 | 40 | 0.380 |
Why?
|
| Liver | 1 | 2017 | 875 | 0.370 |
Why?
|
| Patient Care Team | 1 | 2015 | 338 | 0.370 |
Why?
|
| Needles | 2 | 2018 | 63 | 0.370 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 5681 | 0.360 |
Why?
|
| Epithelial Cells | 1 | 2014 | 414 | 0.350 |
Why?
|
| Quality of Health Care | 2 | 2015 | 535 | 0.350 |
Why?
|
| Gynecomastia | 2 | 2018 | 11 | 0.350 |
Why?
|
| Breast Implants | 2 | 2023 | 14 | 0.340 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 103 | 0.330 |
Why?
|
| United States | 16 | 2025 | 8186 | 0.300 |
Why?
|
| Calcinosis | 3 | 2019 | 84 | 0.290 |
Why?
|
| Breast Density | 4 | 2022 | 19 | 0.280 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2019 | 29 | 0.270 |
Why?
|
| Radiologists | 2 | 2019 | 95 | 0.260 |
Why?
|
| Cultural Competency | 2 | 2024 | 58 | 0.240 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 190 | 0.230 |
Why?
|
| Pregnancy, Ectopic | 2 | 2008 | 10 | 0.230 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 63 | 0.220 |
Why?
|
| Meningioma | 1 | 2025 | 65 | 0.220 |
Why?
|
| Molecular Imaging | 1 | 2025 | 52 | 0.220 |
Why?
|
| Vascular Malformations | 1 | 2025 | 22 | 0.220 |
Why?
|
| Central Nervous System | 2 | 2005 | 205 | 0.220 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2025 | 44 | 0.220 |
Why?
|
| Decidua | 1 | 2004 | 3 | 0.220 |
Why?
|
| Patient Preference | 3 | 2025 | 87 | 0.210 |
Why?
|
| Time Factors | 4 | 2025 | 3777 | 0.210 |
Why?
|
| Translating | 1 | 2024 | 21 | 0.210 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2024 | 23 | 0.210 |
Why?
|
| Postoperative Complications | 3 | 2020 | 1336 | 0.200 |
Why?
|
| Hyperplasia | 2 | 2021 | 92 | 0.200 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 161 | 0.200 |
Why?
|
| Renal Dialysis | 1 | 2025 | 191 | 0.200 |
Why?
|
| Communication Barriers | 1 | 2024 | 71 | 0.200 |
Why?
|
| Culture | 1 | 2024 | 82 | 0.200 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 29 | 0.200 |
Why?
|
| Pregnancy | 12 | 2018 | 2401 | 0.190 |
Why?
|
| Image Enhancement | 2 | 2015 | 196 | 0.190 |
Why?
|
| Patient Navigation | 1 | 2023 | 37 | 0.190 |
Why?
|
| Gender Identity | 1 | 2023 | 69 | 0.190 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 2790 | 0.190 |
Why?
|
| Dehydration | 1 | 2022 | 16 | 0.180 |
Why?
|
| Research | 1 | 2023 | 195 | 0.180 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2021 | 3 | 0.180 |
Why?
|
| Thiamine | 1 | 2022 | 21 | 0.180 |
Why?
|
| Clinical Competence | 4 | 2018 | 731 | 0.180 |
Why?
|
| Transaminases | 1 | 2022 | 15 | 0.180 |
Why?
|
| Sexual Behavior | 1 | 2023 | 192 | 0.180 |
Why?
|
| Pericarditis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Observer Variation | 2 | 2020 | 217 | 0.170 |
Why?
|
| Educational Status | 1 | 2023 | 279 | 0.170 |
Why?
|
| Needs Assessment | 1 | 2023 | 201 | 0.170 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 1719 | 0.170 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2021 | 20 | 0.170 |
Why?
|
| Age Factors | 3 | 2020 | 1595 | 0.170 |
Why?
|
| Serine | 1 | 2022 | 90 | 0.170 |
Why?
|
| Prostatic Hyperplasia | 1 | 2021 | 34 | 0.170 |
Why?
|
| Gestational Age | 6 | 2011 | 196 | 0.170 |
Why?
|
| Transgender Persons | 1 | 2021 | 68 | 0.160 |
Why?
|
| Ischemia | 1 | 2002 | 203 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1117 | 0.160 |
Why?
|
| Quality of Life | 2 | 2025 | 1266 | 0.160 |
Why?
|
| Mammaplasty | 1 | 2020 | 47 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 216 | 0.150 |
Why?
|
| Thrombosis | 1 | 2002 | 207 | 0.150 |
Why?
|
| Thrombectomy | 1 | 2002 | 263 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 46 | 0.150 |
Why?
|
| Cryptococcosis | 1 | 2020 | 75 | 0.150 |
Why?
|
| Iohexol | 1 | 2019 | 18 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 532 | 0.140 |
Why?
|
| Glucose | 1 | 2022 | 478 | 0.140 |
Why?
|
| Mastodynia | 1 | 2018 | 3 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 326 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2025 | 3339 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 102 | 0.140 |
Why?
|
| Papilloma | 1 | 2018 | 12 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 231 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 378 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2021 | 338 | 0.140 |
Why?
|
| Educational Measurement | 2 | 2017 | 214 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2020 | 222 | 0.130 |
Why?
|
| Menopause | 1 | 2020 | 257 | 0.130 |
Why?
|
| Male | 10 | 2025 | 31403 | 0.130 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 94 | 0.130 |
Why?
|
| Job Satisfaction | 1 | 2018 | 144 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 98 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 309 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 74 | 0.120 |
Why?
|
| Carcinoma | 1 | 2017 | 130 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2018 | 145 | 0.120 |
Why?
|
| Osteoarthritis, Knee | 1 | 2021 | 401 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2016 | 37 | 0.120 |
Why?
|
| Ultrasonography | 3 | 2010 | 491 | 0.120 |
Why?
|
| Internship and Residency | 3 | 2017 | 800 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 281 | 0.110 |
Why?
|
| Mucocele | 1 | 2015 | 2 | 0.110 |
Why?
|
| Patient Care | 1 | 2015 | 79 | 0.110 |
Why?
|
| Central Nervous System Diseases | 2 | 2008 | 57 | 0.110 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2015 | 16 | 0.110 |
Why?
|
| Vacuum | 1 | 2014 | 8 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2016 | 296 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 645 | 0.100 |
Why?
|
| Transsexualism | 1 | 2014 | 14 | 0.100 |
Why?
|
| Health Care Reform | 1 | 2015 | 86 | 0.100 |
Why?
|
| Health Promotion | 1 | 2018 | 523 | 0.100 |
Why?
|
| Culturally Competent Care | 2 | 2024 | 17 | 0.100 |
Why?
|
| Patient Positioning | 1 | 2014 | 52 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 711 | 0.100 |
Why?
|
| Curriculum | 4 | 2023 | 609 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 799 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 56 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1377 | 0.090 |
Why?
|
| Fibroadenoma | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pregnancy Outcome | 3 | 2011 | 202 | 0.090 |
Why?
|
| Prevalence | 2 | 2015 | 1453 | 0.080 |
Why?
|
| Septum Pellucidum | 1 | 2011 | 4 | 0.080 |
Why?
|
| Pain | 2 | 2025 | 400 | 0.080 |
Why?
|
| Adolescent | 4 | 2025 | 6367 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1663 | 0.080 |
Why?
|
| Echoencephalography | 1 | 2009 | 14 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 132 | 0.070 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 71 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1060 | 0.070 |
Why?
|
| Adnexal Diseases | 1 | 2008 | 8 | 0.070 |
Why?
|
| Mastectomy | 2 | 2020 | 56 | 0.070 |
Why?
|
| Boston | 2 | 2020 | 259 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2021 | 5834 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2024 | 2115 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 4882 | 0.060 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 63 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 319 | 0.050 |
Why?
|
| Silicones | 1 | 2023 | 14 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 344 | 0.050 |
Why?
|
| Breast Implantation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2023 | 149 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 77 | 0.050 |
Why?
|
| Thorax | 1 | 2003 | 35 | 0.050 |
Why?
|
| Physical Examination | 1 | 2023 | 109 | 0.050 |
Why?
|
| Fetus | 1 | 2003 | 103 | 0.050 |
Why?
|
| Organoids | 1 | 2023 | 44 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 606 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 87 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 135 | 0.040 |
Why?
|
| Rheology | 1 | 2002 | 86 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 183 | 0.040 |
Why?
|
| Colchicine | 1 | 2021 | 29 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2021 | 52 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 80 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 423 | 0.040 |
Why?
|
| Prostate | 1 | 2021 | 123 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2021 | 128 | 0.040 |
Why?
|
| Counseling | 1 | 2003 | 376 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 242 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 122 | 0.040 |
Why?
|
| Knee Joint | 1 | 2021 | 312 | 0.040 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 142 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 2018 | 14 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 196 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2019 | 98 | 0.030 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 79 | 0.030 |
Why?
|
| Communication | 1 | 2023 | 608 | 0.030 |
Why?
|
| Lactation | 1 | 2018 | 77 | 0.030 |
Why?
|
| Infant | 1 | 2023 | 1718 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2018 | 117 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 214 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 726 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1029 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 770 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 61 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 93 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 147 | 0.030 |
Why?
|
| Massachusetts | 1 | 2019 | 2158 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 213 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 559 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Professional Practice | 1 | 2008 | 23 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2008 | 18 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 104 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1274 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5476 | 0.010 |
Why?
|
| Reference Standards | 1 | 2002 | 77 | 0.010 |
Why?
|
| Endosonography | 1 | 2002 | 27 | 0.010 |
Why?
|
| Abdomen | 1 | 2002 | 97 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 413 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2002 | 127 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2002 | 247 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 488 | 0.010 |
Why?
|